Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells.
about
Metabolic functions of FABPs--mechanisms and therapeutic implicationsInflammation and metabolic dysfunction: links to cardiovascular diseasesBMS309403 stimulates glucose uptake in myotubes through activation of AMP-activated protein kinaseCrossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction.Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway.Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammationEndothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging.Positive correlation of serum adipocyte fatty acid binding protein levels with carotid-femoral pulse wave velocity in geriatric populationSmall lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevationA-FABP and oxidative stress underlie the impairment of endothelium-dependent relaxations to serotonin and the intima-medial thickening in the porcine coronary artery with regenerated endothelium.Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease.IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.A-FABP mediates adaptive thermogenesis by promoting intracellular activation of thyroid hormones in brown adipocytes.Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease.Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction.Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis.Endothelial dysfunction and vascular disease - a 30th anniversary update.Lipid chaperones and metabolic inflammation.Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cellsCytoprotective role of the fatty acid binding protein 4 against oxidative and endoplasmic reticulum stress in 3T3-L1 adipocytes.Fenugreek supplementation during high-fat feeding improves specific markers of metabolic healthA vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target.Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects.BMS309403 directly suppresses cardiac contractile function.Vasculo-protective effect of BMS-309403 is independent of its specific inhibition of fatty acid-binding protein 4.
P2860
Q26799705-66B76E38-43A2-4AF8-8C53-EFEEACC61B4BQ26851186-7F506277-8F72-4CE6-B208-CC383C7A8C9FQ28483273-12AC5D91-5DA9-43F5-A85B-B5BA27BF8BA2Q33885504-E86389D9-BE75-4A64-9ACD-3B0433F77FBFQ34704298-9E7B8525-4B68-46F9-AF2C-39452323DCD4Q35042217-0CA344CB-8BC1-408D-9F5A-EB65178F6A05Q35060802-DCA624DC-D28A-4E6B-8773-593F1363AC92Q35109615-7B2B506D-5F55-47CB-A419-88D56A4C672FQ35636955-FD89E27B-27A5-4F4D-968F-65638AFB3BB3Q35709448-5826CA43-F2BE-4696-BE52-8EACA8F6F264Q35859743-8F191F60-0EEC-4C6F-9DA5-878E8DEA4996Q36254291-F8797B2B-0BCA-46F5-9585-6DED22CA1351Q36540923-F6FCE012-63FF-44B4-8DC6-05CC96872BB9Q37070686-4DAD73BA-32FE-417B-BAE5-C04BB056AF89Q37305013-DC5528D9-BE18-44B3-A40B-889D09E47A17Q37622432-3730BC96-00B8-49F2-B23F-F38A33A883FBQ37972596-57F837D4-8213-4D36-AC2A-744D3DA9BECAQ38050907-0642AFAD-85CA-4D1A-ABF7-5C8C8B94BD08Q38071250-0752EF42-4AB4-442D-AAD1-AB97DFA07C3CQ38161454-0EE3FBEB-FD1D-4F50-B1D9-A30A2C83DFADQ38680112-E0789DB7-2DE1-43AD-9A8B-EB554B2909A3Q38908903-07E18F3C-8079-4648-95CA-08E33DAE71BDQ41680356-D9BE57B6-C8CB-416D-B2E2-74D42276B0F6Q42176712-5C36831A-EDF4-4445-8C5F-0931464F2CCAQ42371769-94CF1C3A-0260-47C2-9A21-EF2BC64D7ADDQ47674218-79B2BA4D-294B-4366-8108-91711C59D4DDQ47806448-A416055C-2EF9-4415-B67B-120766AD3177Q48826496-A2F7955E-7CF4-4BB9-A00E-C620175437F0Q50730906-218BA35F-5688-44A6-895B-856BDB0C54BC
P2860
Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chronic administration of BMS3 ...... tured human endothelial cells.
@ast
Chronic administration of BMS3 ...... tured human endothelial cells.
@en
Chronic administration of BMS3 ...... tured human endothelial cells.
@nl
type
label
Chronic administration of BMS3 ...... tured human endothelial cells.
@ast
Chronic administration of BMS3 ...... tured human endothelial cells.
@en
Chronic administration of BMS3 ...... tured human endothelial cells.
@nl
prefLabel
Chronic administration of BMS3 ...... tured human endothelial cells.
@ast
Chronic administration of BMS3 ...... tured human endothelial cells.
@en
Chronic administration of BMS3 ...... tured human endothelial cells.
@nl
P2093
P2860
P1476
Chronic administration of BMS3 ...... tured human endothelial cells.
@en
P2093
Huiying Li
Mary Yk Lee
Zhiguang Zhou
P2860
P304
P356
10.1111/J.1476-5381.2010.01158.X
P407
P577
2011-04-01T00:00:00Z